Anderson-Fabry disease in kidneys from deceased donor

N Basic-Jukic1, M Coric, P Kes

  • 1Department of dialysis, University Hospital Centre Zagreb, Zagreb, Croatia. nina_basic@net.hr

Insights

Anderson-Fabry disease (AFD) was identified in a deceased kidney donor, marking the first such case in a transplant. This discovery highlights the importance of screening for rare genetic disorders in organ donation.

Area of Science:

  • Nephrology
  • Genetics
  • Transplantation Immunology

Background:

  • Anderson-Fabry disease (AFD) is a rare X-linked lysosomal storage disorder.
  • It causes globotriaosylceramide accumulation, affecting organs and vascular endothelium.
  • Patients often develop end-stage renal disease requiring transplantation.

Observation:

  • Two patients with end-stage renal disease received kidney allografts from a deceased female donor.
  • One recipient showed rising creatinine and proteinuria post-transplant.
  • Renal biopsies revealed characteristic cellular changes, including foamy podocytes and lysosomal inclusions.

Findings:

  • Pathological findings in recipients suggested AFD in the donor.
  • Electron microscopy confirmed dense lysosomal granules (myelin figures, zebra bodies) in mesangial cells and podocytes.
  • This is the first reported case of AFD identified in a deceased organ donor's kidney allograft.

Implications:

  • Highlights the potential for transmitting rare genetic diseases through organ transplantation.
  • Suggests the need for enhanced screening protocols for deceased donors.
  • Emphasizes the importance of considering rare genetic conditions in transplant recipients with unexplained graft dysfunction.